Protein-bound uremic toxins, inflammation and oxidative stress: a Cross-sectional study in stage 34 chronic kidney disease
Patients exploring medical weight loss today should focus on FDA-approved options discussed within a structured medical program, such as those outlined on our Peptides overview page
Medical community engagement and professional education programs are building physician confidence in prescribing GLP-1 medications for obesity management
In 2025, nearly three-quarters (72%) face an out-of-pocket maximum of more than $3,000 for single coverage, including one in five (21%) who face an out-of-pocket maximum of more than $6,000
Alanine Aminotransferase (ALT)
Stay at the lowest effective dose if 1mg achieves clinical targets, there is no cost reason to titrate to 2mg